References
- Brown RS. Autoimmune thyroid disease: unlocking a complex puzzle. Curr Opin Pediatr. 2009;21(4):523–528.
- Gianoukakis AG, Khadavi N, Smith TJ. Cytokines, Graves’ disease, and thyroid-associated ophthalmopathy. Thyroid. 2008;18(9):953–958.
- Phenekos C, Vryonidou A, Gritzapis AD, et al. Th1 and Th2 serum cytokine profiles characterize patients with Hashimoto’s thyroiditis (Th1) and Graves’ disease (Th2). Neuroimmunomodulation. 2004;11(4):209–213.
- Lin JD, Wang YH, Fang WF, et al. Serum BAFF and thyroid autoantibodies in autoimmune thyroid disease. Clin Chim Acta. 2016;462:96–102.
- Wakelkamp IM, Gerding MN, Van Der Meer JW, et al. Both Th1- and Th2-derived cytokines in serum are elevated in Graves’ ophthalmopathy. Clin Exp Immunol. 2000;121(3):453–457.
- Salvi M, Pedrazzoni M, Girasole G, et al. Serum concentrations of proinflammatory cytokines in Graves’ disease: effect of treatment, thyroid function, ophthalmopathy and cigarette smoking. Eur J Endocrinol. 2000;143:197–202.
- Tamaru M, Matsuura B, Onji M. Increased levels of serum interleukin-12 in Graves’ disease. Eur J Endocrinol. 1999;141:111–116.
- Miyauchi S, Matsuura B, Onji M. Increased levels of serum interleukin-18 in Graves’ disease. Thyroid. 2000;10(9):815–819.
- Mikos H, Mikos M, Rabska-Pietrzak B, et al. The clinical role of serum concentrations of selected cytokines: IL-1beta, TNF-alpha and IL-6 in diagnosis of autoimmune thyroid disease (AITD) in children. Autoimmunity. 2014;47(7):466–472.
- Senturk T, Kozaci LD, Kok F, et al. Proinflammatory cytokine levels in hyperthyroidism. Clin Invest Med. 2003;26:58–63.
- Alnaqdy A, Al-Maskari M. Levels of cytokines and thyroid autoantibodies in Omani patients with Graves’ disease. Br J Biomed Sci. 2007;64(4):164–167.
- Kokkotou E, Marafelia P, Mantzos EI, et al. Serum monocyte chemoattractant protein-1 is increased in chronic autoimmune thyroiditis. Metabolism. 2002;51(11):1489–1493.
- Kemp EH, Metcalfe RA, Smith KA, et al. Detection and localization of chemokine gene expression in autoimmune thyroid disease. Clin Endocrinol. 2003;59(2):207–213.
- Hiratsuka I, Itoh M, Yamada H, et al. Simultaneous measurement of serum chemokines in autoimmune thyroid diseases: possible role of IP-10 in the inflammatory response. Endocr J. 2015;62(12):1059–1066.
- Antonelli A, Fallahi P, Rotondi M, et al. Serum levels of the interferon-gamma-inducible alpha chemokine CXCL10 in patients with active Graves’ disease, and modulation by methimazole therapy and thyroidectomy. Br J Surg. 2006;93(10):1226–1231.
- Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev. 1997;18(1):4–25.
- Iitaka M, Noh JY, Kitahama S, et al. Elevated serum granulocyte colony-stimulating factor levels in patients with Graves’ disease. Clin Endocrinol. 1998;48(3):275–280.
- Ye X, Liu J, Wang Y, et al. Increased serum VEGF and b-FGF in Graves’ ophthalmopathy. Graefes Arch Clin Exp Ophthalmol. 2014;252(10):1639–1644.
- Liu Y, Tang J, Hu Q, et al. A preliminary study on the expression and clinical value of platelet-derived growth factor BB, hypoxia inducible factor-1alpha and C-C motif chemokine receptor-2 in peripheral blood during the pathogenesis of Graves’ disease. Endokrynologia Polska. 2018;69(1):9–15.
- Lin JD, Wang YH, Liu CH, et al. Association of IRF8 gene polymorphisms with autoimmune thyroid disease. Eur J Clin Invest. 2015;45(7):711–719.
- Simera I, Moher D, Hoey J, et al. A catalogue of reporting guidelines for health research. Eur J Clin Invest. 2010;40(1):35–53.
- Sanders J, Oda Y, Roberts S, et al. The interaction of TSH receptor autoantibodies with 125I-labelled TSH receptor. J Clin Endocrinol Metab. 1999;84(10):3797–3802.
- Ajjan RA, Weetman AP. Cytokines in thyroid autoimmunity. Autoimmunity. 2003;36(6–7):351–359.
- Tomer Y. Hepatitis C and interferon induced thyroiditis. J Autoimmun. 2010;34(3):J322–J326.
- Al-Humaidi MA. Serum cytokines levels in Graves’ disease. Saudi Med J. 2000;21:639–644.
- Shen J, Li Z, Li W, et al. Th1, Th2, and Th17 cytokine involvement in thyroid associated ophthalmopathy. Dis Markers. 2015;2015:1–6.
- Esfahanian F, Ghelich R, Rashidian H, et al. Increased levels of serum interleukin-17 in patients with Hashimoto’s thyroiditis. Indian J Endocr Metab. 2017;21(4):551–554.
- Hidaka Y, Okumura M, Shimaoka Y, et al. Increased serum concentration of interleukin-5 in patients with Graves’ disease and Hashimoto’s thyroiditis. Thyroid. 1998;8(3):235–239.
- Vannucchi G, Covelli D, Curro N, et al. Serum BAFF concentrations in patients with Graves’ disease and orbitopathy before and after immunosuppressive therapy. J Clin Endocrinol Metab. 2012;97(5):E755–759.
- Turner MD, Nedjai B, Hurst T, et al. Cytokines and chemokines: at the crossroads of cell signalling and inflammatory disease. Biochim Biophys Acta. 2014;1843(11):2563–2582.
- Gupta S. Tumor necrosis factor-alpha-induced apoptosis in T cells from aged humans: a role of TNFR-I and downstream signaling molecules. Exp Gerontol. 2002;37(2–3):293–299.
- Yamamoto K, Itoh M, Okamura T, et al. Relative levels of the inflammatory cytokine TNFalpha and the soluble CD40 ligand profile in serum correlate with the thyrotoxic activity of Graves’ disease. Thyroid. 2012;22(5):516–521.
- Sato K, Satoh T, Shizume K, et al. Inhibition of 125I organification and thyroid hormone release by interleukin-1, tumor necrosis factor-alpha, and interferon-gamma in human thyrocytes in suspension culture. J Clin Endocrinol Metab. 1990;70(6):1735–1743.
- Ajjan RA, Watson PF, Weetman AP. Cytokines and thyroid function. Adv Neuroimmunol. 1996;6(4):359–386.
- Diny NL, Rose NR, Čiháková D. Eosinophils in autoimmune diseases. Front Immunol. 2017;8:484.